![](/img/cover-not-exists.png)
6079 Overall survival of patients with KRAS wild-type tumours treated with FOLFOX4± cetuximab as 1st-line treatment for metastatic colorectal cancer: The OPUS study
Bokemeyer, C., Bondarenko, I., Hartmann, J.T., DeBraud, F., Schuch, G., Zubel, A., Celik, I., Koralewski, P.Volume:
7
Language:
english
Journal:
European Journal of Cancer Supplements
DOI:
10.1016/S1359-6349(09)71174-7
Date:
September, 2009
File:
PDF, 49 KB
english, 2009